FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eva Gerdts

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Heart Ventricles

Procedures

Physiology

Ventricular Function, Left

Concepts & Ideas

Co-author Network

Publications

TOP 3
Anders M Greve; Lars Køber; Christoph A Nienaber; Terje R Pedersen; Simon Ray; Anne B Rossebø; Kurt Boman; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study.
Marina De Marco; Kurt Boman; Giuseppina Casalnuovo; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Jorge R Kizer; Teresa Migliore; Michael H Olsen; Kristian Wachtell; Giovanni de Simone
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.
Pilly Chillo; Janet Lutale; Johnson Lwakatare; Ashild E Rieck; Eva Gerdts
Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eva Gerdts (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anders M Greve; Lars Køber; Christoph A Nienaber; Terje R Pedersen; Simon Ray; Anne B Rossebø; Kurt Boman; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study.
International journal of cardiology 2013;166(1):72-6.
2013: Marina De Marco; Kurt Boman; Giuseppina Casalnuovo; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Jorge R Kizer; Teresa Migliore; Michael H Olsen; Kristian Wachtell; Giovanni de Simone
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.
American journal of hypertension 2013;26(4):567-73.
2013: Pilly Chillo; Janet Lutale; Johnson Lwakatare; Ashild E Rieck; Eva Gerdts
Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients.
Blood pressure 2013;22(2):86-93.
2013: Eva Gerdts; B P Lund; Markku S Nieminen; Peter M Okin; Kristian Wachtell; K Boman; Björn Dahlöf; G de Simone; R B Devereux
Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2013;23(2):122-9.
2012: Mai Tone Lønnebakken; Eva Gerdts; OM Pedersen
Femoral pseudoaneurysm with a communicating arteriovenous fistula: a complication after percutaneous coronary intervention.
Circulation 2012;126(11):e161-2.
2012: Anders M Greve; Mai T Lønnebakken; Markku S Nieminen; Peter M Okin; Michael H Olsen; Per Omvik; Vittorio Palmieri; Jonathan Bella; Kurt Boman; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Kristian Wachtell
Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study.
American journal of hypertension 2012;25(9):1017-23.
2012: Asle Hirth; Kjetil Lenes; Nicola C Edwards; Eva Gerdts; Gottfried Greve; Trine Tangeraas; Gunnar Norgård
Left ventricular function in children and adults after renal transplantation in childhood.
Pediatric nephrology (Berlin, Germany) 2012;27(9):1565-74.
2012: Åshild E Rieck; Kurt Boman; Dana Cramariuc; Christa Gohlke-Bärwolf; Mai Tone Lønnebakken; Anne B Rossebø; Eva M Staal; Eva Gerdts
Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
Hypertension 2012;60(1):90-7.
2012: Giuseppina Casalnuovo; Marina De Marco; Giovanni de Simone; Eva Gerdts; Renata Giudice; Raffaele Izzo; Bruno Trimarco; Nicola De Luca
Arterial stiffness is associated with carotid atherosclerosis in hypertensive patients (the Campania Salute Network).
American journal of hypertension 2012;25(7):739-45.
2012: Eva Gerdts
Left atrial enlargement: a prevalent marker of hypertensive heart disease.
Blood pressure 2012;21(2):71-2.
2012: Anders M Greve; Lars Køber; Simon Ray; Anne B Rossebø; Kurt Boman; Richard B Devereux; Eva Gerdts; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.
Journal of the American College of Cardiology 2012;59(13):1142-9.
2012: Ingar Holme; Y Antero Kesäniemi; William Malbecq; Terje R Pedersen; Simon Ray; Anne B Rossebø; Kristian Wachtell; Ronnie Willenheimer; Kurt Boman; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis.
Heart (British Cardiac Society) 2012;98(5):377-83.
2012: Ashild E Rieck; Edda Bahlmann; Giovanni Cioffi; Eva Gerdts; Christa Gohlke-Bärwolf; Mai Tone Lønnebakken; Simon Ray; Dana Cramariuc
Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial).
Cardiovascular ultrasound 2012;10():43.
2011: Mai T Lønnebakken; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Eva Gerdts; Richard B Devereux
In-treatment stroke volume predicts cardiovascular risk in hypertension.
Journal of hypertension 2011;29(8):1508-14.
2011: Mai Tone Lønnebakken; Eva M Staal; Jan Erik Nordrehaug; Eva Gerdts
Usefulness of contrast echocardiography for predicting the severity of angiographic coronary disease in non-ST-elevation myocardial infarction.
The American journal of cardiology 2011;107(9):1262-7.
2011: Nikolaus Jander; Jan Minners; Ingar Holme; Eva Gerdts; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Anne Rossebø; Terje R Pedersen; Terje Skjaerpe; Ronnie Willenheimer; Kristian Wachtell; Franz-Josef Neumann; Christa Gohlke-Bärwolf
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
Circulation 2011;123(8):887-95.
2010: Eva Gerdts; Anne Bjørhovde Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John Boyd Chambers; Kenneth Egstrup; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
The American journal of cardiology 2010;106(11):1634-9.
2010: Kristian Wachtell; Vittorio Palmieri; Eva Gerdts; Jonathan Bella; Gerard P Aurigemma; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Hans Ibsen; Jens E Rokkedal; Richard B Devereux
Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
The American journal of cardiology 2010;106(7):999-1005.
2010: Peter M Okin; Eva Gerdts; Kristian Wachtell; Lasse Oikarinen; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation.
Journal of hypertension 2010;28(7):1534-40.
2010: Silvana Cicala; Giovanni de Simone; Eva Gerdts; Björn Dahlöf; Lars H Lindholm; Sverre E Kjeldsen; Richard B Devereux
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2010;28(6):1134-40.
2010: Kristian Wachtell; Eva Gerdts; Gerard P Aurigemma; Kurt Boman; Björn Dahlöf; Markku S Nieminen; Michael H Olsen; Peter M Okin; Vittorio Palmieri; Jens E Rokkedal; Richard B Devereux
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
Blood pressure 2010;19(3):169-75.
2010: Nora Tuseth; Dana Cramariuc; Ashild E Rieck; Kristian Wachtell; Eva Gerdts
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).
Blood pressure 2010;19(3):140-4.
2010: Barbara P Lund; Christa Gohlke-Bärwolf; Dana Cramariuc; Anne B Rossebø; Ashild E Rieck; Eva Gerdts
Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
The American journal of cardiology 2010;105(10):1456-60.
2010: Marcus Lund Frølich; Einar Skulstad Davidsen; Mai Tone Lønnebakken; Eva Gerdts
An unusual location of a papillary fibroelastoma.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2010;11(4):E10.
2010: Ashild E Rieck; Dana Cramariuc; Eva M Staal; Anne B Rossebø; Kristian Wachtell; Eva Gerdts
Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy).
Journal of hypertension 2010;28(2):377-83.
2010: Dana Cramariuc; Eva Gerdts; Einar Skulstad Davidsen; Leidulf Segadal; Knut Matre
Myocardial deformation in aortic valve stenosis: relation to left ventricular geometry.
Heart (British Cardiac Society) 2010;96(2):106-12.
2009: Giovanni de Simone; Peter M Okin; Eva Gerdts; M H Olsen; Kristian Wachtell; Darcy A Hille; Björn Dahlöf; Sverre E Kjeldsen; Richard B Devereux
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(9):634-40.
2009: Marcello Chinali; Gerard P Aurigemma; Giovanni de Simone; Rakesh K Mishra; Eva Gerdts; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Richard B Devereux
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).
The American journal of cardiology 2009;104(8):1098-104.
2009: Dana Cramariuc; Giovanni Cioffi; Ashild E Rieck; Richard B Devereux; Eva M Staal; Simon Ray; Kristian Wachtell; Eva Gerdts
Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy.
JACC. Cardiovascular imaging 2009;2(4):390-9.
2009: Kurt Boman; Eva Gerdts; Kristian Wachtell; Björn Dahlöf; Markku S Nieminen; Mona Olofsson; Vasilios Papademetriou; Richard B Devereux
Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(2):242-8.
2009: Einar Skulstad Davidsen; Tor Hervig; Per Omvik; Eva Gerdts
Left ventricular long-axis function in treated haemochromatosis.
The international journal of cardiovascular imaging 2009;25(3):237-47.
2009: Einar Skulstad Davidsen; Per Omvik; Tor Hervig; Eva Gerdts
Left ventricular diastolic function in patients with treated haemochromatosis.
Scandinavian cardiovascular journal : SCJ 2009;43(1):32-8.
2009: Mai Tone Lønnebakken; Eva Gerdts; Jan Wirsching; OM Pedersen
Ultrasound in evaluation of post-interventional femoral vein obstruction: a case report.
Cardiovascular ultrasound 2009;7():14.
2009: Mai Tone Lønnebakken; Oyvind Bleie; Elin Strand; Eva M Staal; Ottar K Nygård; Eva Gerdts
Myocardial contrast echocardiography in assessment of stable coronary artery disease at intermediate dobutamine-induced stress level.
Echocardiography (Mount Kisco, N.Y.) 2009;26(1):52-60.
2008: Jone Furlund Owe; Einar Skulstad Davidsen; Geir Egil Eide; Eva Gerdts; Nils Erik Gilhus
Left ventricular long-axis function in myasthenia gravis.
Journal of neurology 2008;255(11):1777-84.
2008: Eva Gerdts; Dana Cramariuc; Giovanni de Simone; Kristian Wachtell; Björn Dahlöf; Richard B Devereux
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2008;9(6):809-15.
2008: Marcello Chinali; Giovanni de Simone; Kristian Wachtell; Eva Gerdts; Julius M Gardin; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf; Richard B Devereux
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2008;26(7):1472-6.
2008: Eva Gerdts; Peter M Okin; Giovanni de Simone; Dana Cramariuc; Kristian Wachtell; Kurt Boman; Richard B Devereux
Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Hypertension 2008;51(4):1109-14.
2008: Dana Cramariuc; Ashild E Rieck; Eva M Staal; Kristian Wachtell; Erlend Eriksen; Anne B Rossebø; Eva Gerdts
Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).
The American journal of cardiology 2008;101(4):510-5.
2008: Mai Tone Lønnebakken; Eva Gerdts
Libman-Sacks endocarditis and cerebral embolization in antiphospholipid syndrome.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2008;9(1):192-3.
2008: M T Lønnebakken; Gottfried Greve; E Leirgul; Eva Gerdts
Brain abscess caused by paradoxical embolization in Ebstein's anomaly.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2008;9(1):105-6.
2007: Einar Skulstad Davidsen; Knut Liseth; Per Omvik; Tor Hervig; Eva Gerdts
Reduced exercise capacity in genetic haemochromatosis.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(3):470-5.
2007: Vittorio Palmieri; Peter M Okin; Giovanni de Simone; Jonathan Bella; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Journal of hypertension 2007;25(5):1079-85.
2007: Eva Gerdts; Kristian Wachtell; Per Omvik; Jan Erik Otterstad; Lasse Oikarinen; Kurt Boman; Björn Dahlöf; Richard B Devereux
Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
Hypertension 2007;49(2):311-6.
2006: Vittorio Palmieri; Peter M Okin; Jonathan Bella; Kristian Wachtell; Lasse Oikarinen; Eva Gerdts; Kurt Boman; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2006;24(10):2079-84.
2006: Dana Cramariuc; Eva Gerdts; Leidulf Segadal
Impact of hypertension on left ventricular hypertrophy regression and exercise capacity in patients operated for aortic valve stenosis.
Scandinavian cardiovascular journal : SCJ 2006;40(3):167-74.
2006: Peter M Okin; Richard B Devereux; Eva Gerdts; Steven M Snapinn; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Jonathan Edelman; Lars H Lindholm; Björn Dahlöf
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Circulation 2006;113(12):1588-96.
2006: Eva Gerdts; Hans Björnstad; Richard B Devereux; Per Lund-Jhansen; Einar S Davidsen; Per Omvik
Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy).
Blood pressure 2006;15(4):220-6.
2005: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Vittorio Palmieri; Eva Gerdts; Gunnar Smith; Markku S Nieminen; Björn Dahlöf; Hans Ibsen; Richard B Devereux
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy.
American journal of hypertension 2005;18(11):1430-6.
2005: Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):712-9.
2005: Kristian Wachtell; Björn Hornestam; Mika Lehto; David Slotwiner; Eva Gerdts; Michael H Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Jens Rokkedal; Richard B Devereux
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):705-11.
2005: Kurt Boman; Mona Olofsson; Björn Dahlöf; Eva Gerdts; Markku S Nieminen; Vasilios Papademetriou; Kristian Wachtell; Richard B Devereux
Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study).
The American journal of cardiology 2005;95(2):280-3.
2005: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Eva Gerdts; Vittorio Palmieri; Markku S Nieminen; Gunnar Smith; Hans Ibsen; Richard B Devereux
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy).
The American journal of cardiology 2005;95(1):132-6.
2004: Richard B Devereux; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine Harris; Peter Aurup; Björn Dahlöf
Prognostic significance of left ventricular mass change during treatment of hypertension.
JAMA : the journal of the American Medical Association 2004;292(19):2350-6.
2004: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Jennifer E Liu; Kurt Boman; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Jens Rokkedal; Björn Dahlöf; Richard B Devereux
Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).
The American journal of cardiology 2004;94(8):1076-80.
2004: Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan Edelman; Kristian Wachtell
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Circulation 2004;110(11):1456-62.
2004: Kristian Wachtell; Vasilios Papademetriou; Gunnar Smith; Eva Gerdts; Björn Dahlöf; Erik Engblom; Gerard P Aurigemma; Jonathan Bella; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
American heart journal 2004;148(3):538-44.
2004: Eva M Staal; Ottar Nygård; Per Omvik; Eva Gerdts
Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians.
Blood pressure monitoring 2004;9(3):167-72.
2004: Eva Gerdts; M J Roman; V Palmieri; Kristian Wachtell; G Smith; M S Nieminen; B Dahlöf; Richard B Devereux
Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study).
Journal of human hypertension 2004;18(6):417-22.
2004: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Vittorio Palmieri; Eva Gerdts; G Smith; Markku S Nieminen; B Dahlöf; Hans Ibsen; Richard B Devereux
Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy.
Journal of human hypertension 2004;18(6):453-9.
2004: Z B Li; Kristian Wachtell; Peter M Okin; Eva Gerdts; Jennifer E Liu; Markku S Nieminen; Sverker Jern; Björn Dahlöf; Richard B Devereux
Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):397-402.
2004: J Kontos; V Papademetriou; K Wachtell; V Palmieri; Jennifer E Liu; Eva Gerdts; K Boman; M S Nieminen; B Dahlöf; R B Devereux
Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):431-6.
2004: Jonathan Bella; Vittorio Palmieri; Kristian Wachtell; Jennifer E Liu; Eva Gerdts; Markku S Nieminen; MJ Koren; Miguel Zabalgoitia; J T Wright; Björn Dahlöf; Richard B Devereux
Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study.
Journal of human hypertension 2004;18(6):411-6.
2004: Vittorio Palmieri; Kristian Wachtell; Jonathan Bella; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Björn Dahlöf; M J Roman; Richard B Devereux
Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):423-30.
2004: Eva Gerdts; Per Omvik; Rune Mo; Sverre E Kjeldsen
[Hypertension and heart disease].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(6):802-5.
2003: Vittorio Palmieri; Jonathan Bella; Mary J Roman; Eva Gerdts; Vasilios Papademetriou; Kristian Wachtell; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study.
Journal of hypertension 2003;21(4):781-7.
2003: Gerard P Aurigemma; Richard B Devereux; Kristian Wachtell; Vittorio Palmieri; Kurt Boman; Eva Gerdts; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf
Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment.
American journal of hypertension 2003;16(3):180-6.
2003: Vittorio Palmieri; Peter M Okin; Jonathan Bella; Eva Gerdts; Kristian Wachtell; Julius Gardin; Vasilios Papademetriou; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Hypertension 2003;41(1):75-82.
2002: Kristian Wachtell; Björn Dahlöf; Jens Rokkedal; Vasilios Papademetriou; Markku S Nieminen; Gunnar Smith; Eva Gerdts; Kurt Boman; Jonathan Bella; Richard B Devereux
Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
American heart journal 2002;144(6):1057-64.
2002: Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Gunnar Smith; Björn Dahlöf; Gerard P Aurigemma; Richard B Devereux
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study.
Circulation 2002;106(2):227-32.
2002: Richard B Devereux; Vittorio Palmieri; Jennifer E Liu; Kristian Wachtell; Jonathan Bella; Kurt Boman; Eva Gerdts; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
Journal of hypertension 2002;20(7):1445-50.
2002: Eva Gerdts; Hans Bjornstad; Sigurd Toft; Richard B Devereux; Per Omvik
Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy).
Journal of hypertension 2002;20(6):1223-9.
2002: Kristian Wachtell; Jonathan Bella; Jens Rokkedal; Vittorio Palmieri; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Eva Gerdts; Richard B Devereux
Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Circulation 2002;105(9):1071-6.
2002: Eva Gerdts; Lasse Oikarinen; Vittorio Palmieri; Jan Erik Otterstad; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Richard B Devereux
Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Hypertension 2002;39(3):739-43.
2002: Eva Gerdts; Vasilios Papademetriou; Vittorio Palmieri; Kurt Boman; Hans Björnstad; Kristian Wachtell; Thomas D Giles; Björn Dahlöf; Richard B Devereux
Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
The American journal of cardiology 2002;89(4):399-402.
2002: Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Jonathan Bella; Tapio Aalto; Björn Dahlöf; Eva Gerdts; Jackson T Wright; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen; Richard B Devereux
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
American heart journal 2002;143(2):319-26.
2002: Jonathan Bella; Kristian Wachtell; Kurt Boman; Vittorio Palmieri; Vasilios Papademetriou; Eva Gerdts; Tapio Aalto; Michael H Olsen; Mona Olofsson; Björn Dahlöf; Mary J Roman; Richard B Devereux
Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study).
The American journal of cardiology 2002;89(3):337-41.
2001: Vittorio Palmieri; Kristian Wachtell; Eva Gerdts; Jonathan Bella; Vasilios Papademetriou; Christian Tuxen; Markku S Nieminen; Björn Dahlöf; Giovanni de Simone; Richard B Devereux
Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
American heart journal 2001;141(5):784-91.
2001: Eva Gerdts; Miguel Zabalgoitia; Hans Björnstad; T L Svendsen; Richard B Devereux
Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
The American journal of cardiology 2001;87(8):980-3; A4.
2001: Richard Devereux; Jonathan Bella; Kurt Boman; Eva Gerdts; Markku S Nieminen; Jens Rokkedal; Vasilios Papademetriou; Kristian Wachtell; J Wright; Mary Paranicas; Peter M Okin; Mary J Roman; G Smith; Björn Dahlöf
Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study.
Blood pressure 2001;10(2):74-82.
2001: Jonathan Bella; Kristian Wachtell; Vittorio Palmieri; P R Liebson; Eva Gerdts; A Ylitalo; MJ Koren; O L Pedersen; Jens Rokkedal; Björn Dahlöf; Mary J Roman; Richard B Devereux
Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study.
Journal of hypertension 2001;19(1):127-34.
2001: Einar Svarstad; Eva Gerdts; Per Omvik; Jarle Ofstad; Bjarne M Iversen
Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus.
Kidney & blood pressure research 2001;24(1):64-70.
2000: Per Omvik; Eva Gerdts; Ole L Myking; Per Lund-Johansen
Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension.
American heart journal 2000;140(4):624-30.
2000: Kristian Wachtell; G Smith; Eva Gerdts; Björn Dahlöf; Markku S Nieminen; Vasilios Papademetriou; Jonathan Bella; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.
The American journal of cardiology 2000;85(4):466-72.
2000: Kristian Wachtell; Jonathan Bella; P R Liebson; Eva Gerdts; Björn Dahlöf; Tapio Aalto; Mary J Roman; Vasilios Papademetriou; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.
Hypertension 2000;35(1 Pt 1):6-12.
1999: Eva Gerdts; Per Lund-Johansen; Per Omvik
Reproducibility of salt sensitivity testing using a dietary approach in essential hypertension.
Journal of human hypertension 1999;13(6):375-84.
1999: Per Omvik; Eva Gerdts; Ole L Myking; Per Lund-Johansen
Similar central hemodynamics in salt-sensitive and salt-resistant hypertensive patients.
Blood pressure 1999;8(4):233-41.
1998: Eva Gerdts; Einar Svarstad; S Aanderud; Ole L Myking; Per Lund-Johansen; Per Omvik
Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months.
American journal of hypertension 1998;11(10):1178-87.
1998: Eva Gerdts; Per Lund-Johansen; Per Omvik
Factors influencing left ventricular mass in salt sensitive and salt resistant essential hypertensive patients.
Blood pressure 1998;7(4):223-30.
1998: Bernd Timmermann; R Mo; Friedrich C Luft; Eva Gerdts; Andreas Busjahn; Per Omvik; G H Li; Herbert Schuster; T F Wienker; Margret R Hoehe; Per Lund-Johansen
Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study.
Kidney international 1998;53(6):1455-60.
1997: Eva Gerdts; Ole L Myking; Per Lund-Johansen; Per Omvik
Factors influencing LVM in hypertensive type-1 diabetic patients.
Blood pressure 1997;6(4):197-202.
1996: Eva Gerdts; E Svarstad; Ole L Myking; Per Lund-Johansen; Per Omvik
Salt sensitivity in hypertensive type-1 diabetes mellitus.
Blood pressure 1996;5(2):78-85.
1994: Eva Gerdts; Ole L Myking; Per Omvik
Salt sensitive essential hypertension evaluated by 24 hour ambulatory blood pressure.
Blood pressure 1994;3(6):375-80.